vs
STANDARD BIOTOOLS INC.（LAB）与OPTICAL CABLE CORP（OCC）财务数据对比。点击上方公司名可切换其他公司
OPTICAL CABLE CORP的季度营收约是STANDARD BIOTOOLS INC.的1.0倍（$19.8M vs $19.6M），OPTICAL CABLE CORP净利率更高（0.2% vs -177.4%，领先177.7%），OPTICAL CABLE CORP同比增速更快（1.8% vs -11.5%），OPTICAL CABLE CORP自由现金流更多（$718.8K vs $-23.1M），过去两年OPTICAL CABLE CORP的营收复合增速更高（15.5% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
光电缆公司总部位于弗吉尼亚州罗阿诺克，主营光纤光缆生产，产品主要应用于电信领域，销售覆盖美国及全球70余个国家，同时也为美国军方生产陆战战术光纤光缆。
LAB vs OCC — 直观对比
营收规模更大
OCC
是对方的1.0倍
$19.6M
营收增速更快
OCC
高出13.2%
-11.5%
净利率更高
OCC
高出177.7%
-177.4%
自由现金流更多
OCC
多$23.8M
$-23.1M
两年增速更快
OCC
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $19.8M |
| 净利润 | $-34.7M | $48.6K |
| 毛利率 | 48.5% | 31.9% |
| 营业利润率 | -168.5% | 1.4% |
| 净利率 | -177.4% | 0.2% |
| 营收同比 | -11.5% | 1.8% |
| 净利润同比 | -28.8% | -87.0% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABOCC
| Q4 25 | — | $19.8M | ||
| Q3 25 | $19.6M | $19.9M | ||
| Q2 25 | $21.8M | $17.5M | ||
| Q1 25 | $40.8M | $15.7M | ||
| Q4 24 | — | $19.5M | ||
| Q3 24 | $22.1M | $16.2M | ||
| Q2 24 | $22.5M | $16.1M | ||
| Q1 24 | $45.5M | $14.9M |
净利润LABOCC
| Q4 25 | — | $48.6K | ||
| Q3 25 | $-34.7M | $301.9K | ||
| Q2 25 | $-33.5M | $-697.9K | ||
| Q1 25 | $-26.0M | $-1.1M | ||
| Q4 24 | — | $373.5K | ||
| Q3 24 | $-26.9M | $-1.6M | ||
| Q2 24 | $-45.7M | $-1.6M | ||
| Q1 24 | $-32.2M | $-1.4M |
毛利率LABOCC
| Q4 25 | — | 31.9% | ||
| Q3 25 | 48.5% | 31.7% | ||
| Q2 25 | 48.8% | 30.4% | ||
| Q1 25 | 48.4% | 29.4% | ||
| Q4 24 | — | 33.5% | ||
| Q3 24 | 54.9% | 24.2% | ||
| Q2 24 | 46.1% | 25.1% | ||
| Q1 24 | 53.1% | 25.0% |
营业利润率LABOCC
| Q4 25 | — | 1.4% | ||
| Q3 25 | -168.5% | 2.8% | ||
| Q2 25 | -118.1% | -2.4% | ||
| Q1 25 | -80.8% | -5.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -120.9% | -8.2% | ||
| Q2 24 | -134.5% | -8.1% | ||
| Q1 24 | -132.2% | -9.4% |
净利率LABOCC
| Q4 25 | — | 0.2% | ||
| Q3 25 | -177.4% | 1.5% | ||
| Q2 25 | -153.7% | -4.0% | ||
| Q1 25 | -63.8% | -7.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | -122.0% | -9.6% | ||
| Q2 24 | -203.3% | -9.9% | ||
| Q1 24 | -70.6% | -9.6% |
每股收益（稀释后）LABOCC
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | $-0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $237.5K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $16.5M |
| 总资产 | $539.6M | $40.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABOCC
| Q4 25 | — | $237.5K | ||
| Q3 25 | $129.4M | $421.4K | ||
| Q2 25 | $158.6M | $894.3K | ||
| Q1 25 | $150.9M | $128.3K | ||
| Q4 24 | — | $244.2K | ||
| Q3 24 | $210.6M | $796.7K | ||
| Q2 24 | $269.8M | $1.1M | ||
| Q1 24 | $287.1M | $221.0K |
总债务LABOCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABOCC
| Q4 25 | — | $16.5M | ||
| Q3 25 | $399.7M | $18.2M | ||
| Q2 25 | $424.5M | $19.1M | ||
| Q1 25 | $454.6M | $19.7M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | $489.3M | $20.4M | ||
| Q2 24 | $510.3M | $21.8M | ||
| Q1 24 | $577.3M | $23.3M |
总资产LABOCC
| Q4 25 | — | $40.1M | ||
| Q3 25 | $539.6M | $40.2M | ||
| Q2 25 | $557.0M | $39.1M | ||
| Q1 25 | $579.6M | $37.8M | ||
| Q4 24 | — | $40.4M | ||
| Q3 24 | $681.5M | $37.6M | ||
| Q2 24 | $708.7M | $39.9M | ||
| Q1 24 | $777.7M | $40.5M |
负债/权益比LABOCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $797.3K |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $718.8K |
| 自由现金流率自由现金流/营收 | -118.1% | 3.6% |
| 资本支出强度资本支出/营收 | 4.5% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 16.40× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $1.1M |
8季度趋势，按日历期对齐
经营现金流LABOCC
| Q4 25 | — | $797.3K | ||
| Q3 25 | $-22.2M | $-2.2M | ||
| Q2 25 | $-20.7M | $141.4K | ||
| Q1 25 | $-30.3M | $2.7M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-27.9M | $552.4K | ||
| Q2 24 | $-39.0M | $373.7K | ||
| Q1 24 | $-62.5M | $-261.1K |
自由现金流LABOCC
| Q4 25 | — | $718.8K | ||
| Q3 25 | $-23.1M | $-2.3M | ||
| Q2 25 | $-22.6M | $73.4K | ||
| Q1 25 | $-35.3M | $2.6M | ||
| Q4 24 | — | $-1.6M | ||
| Q3 24 | $-30.1M | $475.2K | ||
| Q2 24 | $-41.0M | $218.2K | ||
| Q1 24 | $-63.3M | $-341.5K |
自由现金流率LABOCC
| Q4 25 | — | 3.6% | ||
| Q3 25 | -118.1% | -11.4% | ||
| Q2 25 | -103.6% | 0.4% | ||
| Q1 25 | -86.6% | 16.5% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | -136.4% | 2.9% | ||
| Q2 24 | -182.2% | 1.4% | ||
| Q1 24 | -138.9% | -2.3% |
资本支出强度LABOCC
| Q4 25 | — | 0.4% | ||
| Q3 25 | 4.5% | 0.4% | ||
| Q2 25 | 8.7% | 0.4% | ||
| Q1 25 | 12.4% | 0.5% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | 10.2% | 0.5% | ||
| Q2 24 | 8.6% | 1.0% | ||
| Q1 24 | 1.7% | 0.5% |
现金转化率LABOCC
| Q4 25 | — | 16.40× | ||
| Q3 25 | — | -7.29× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -4.08× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
OCC
暂无分部数据
